<DOC>
	<DOCNO>NCT01750476</DOCNO>
	<brief_summary>The investigator conduct research study understand cell responsible fight infection ( immune cell ) affect hormonal contraceptive use . The investigator hypothesize progestin-containing hormonal contraceptive ( i.e. , Depo-Provera ) inhibit host response infection . To test hypothesis , investigator collect blood genital tract sample woman initiation hormonal contraceptive ( either birth control pill , Depo-Provera , Mirena ) .</brief_summary>
	<brief_title>Modulation Mucosal Systemic Immunity Hormonal Contraceptives</brief_title>
	<detailed_description />
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>1 . 1525 year age ( inclusive ) 2 . History regular menstrual cycle 3 . Not pregnant 4 . No plan become pregnant next 3 month 5 . Interested beginning use OC , DMPA , LNGIUD 6 . Able read provide write informed consent ( consent parent/guardian participant minor ) 1 . Anticipated move area prevents return followup visit 2 . Unavailability followup visit 3 . Less 90 day postpartum postabortion 4 . Sexually transmitted infection ( STI ) diagnose less 30 day prior enrollment 5 . Use OC , contraceptive ring patch , single rod implant , LNGIUD , coppercontaining IUD le 3 month prior enrollment 6 . DMPA injection le 6 month prior enrollment 7 . History immunosuppressive condition current use immunosuppressive medication 8 . History cervical malignancy 9 . Detection cervical anatomic pathologic condition preclude cervical biopsy procurement 10 . Intolerance contradiction use OC , DMPA , LNGIUD</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>oral contraception</keyword>
	<keyword>Depo-Provera</keyword>
	<keyword>Mirena</keyword>
</DOC>